Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Fasitibant Low Dose	110
Overall Study	STARTED	Fasitibant Intermediate Dose	110
Overall Study	STARTED	Fasitibant High Dose	108
Overall Study	STARTED	PLACEBO	108
Overall Study	COMPLETED	Fasitibant Low Dose	108
Overall Study	COMPLETED	Fasitibant Intermediate Dose	109
Overall Study	COMPLETED	Fasitibant High Dose	103
Overall Study	COMPLETED	PLACEBO	104
Overall Study	NOT COMPLETED	Fasitibant Low Dose	2
Overall Study	NOT COMPLETED	Fasitibant Intermediate Dose	1
Overall Study	NOT COMPLETED	Fasitibant High Dose	5
Overall Study	NOT COMPLETED	PLACEBO	4

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02205814/flow